Strike.

Recent News

State Street Follows BlackRock With Filing to Challenge Invesco’s QQQ

Photo by Quang Nguyen Vinh via Unsplash

2 min read
ETF Investors Hide Out in Energy Sector amid Iran War

Photo by NASA via Unsplash

2 min read
What, Me Worry? Blackstone Closes $10 Billion Private Credit Fund Amid Industry Turmoil

Photo via IMAGO/Gonzales Photo/Thomas Rasmussen/IMAGO/Gonzales Photo/Newscom

1 min read

JUST FOR FUN

Strike.

If you take your bowling ball to the skate park, you need geometry and phisics to turn a normal throw into a stunning trick shot [source and full video: https://t.co/qZq1Vfhsf7] pic.twitter.com/QSm8pzAE6s
— Massimo (@Rainmaker1973) May 23, 2019

Photo via Christine Olsson/ZUMAPRESS/Newscom

Media & Entertainment

Universal Music Group (Ackman’s Version): Hedge Fund Mogul Makes $63B Takeover Bid

n the proposed deal, UMG would merge with Pershing Square SPARC Holdings, a blank-check special-purpose acquisition rights company.

2 min read
Photo via JOHN ANGELILLO/UPI/Newscom

Big Tech

Goldman Sachs Spots Buying Opportunity in Bruised Big Tech

The Roundhill Magnificent Seven ETF, which tracks Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla, has slid roughly 11% this year.

2 min read

Photo by Samsung Memory via Unsplash

ETF Upside

Roundhill Taps Surging Memory Sector with New ETF

Memory stocks have been surging for the past year.

2 min read
Photo by Yunus Tuğ via Unsplash

Advisor Upside

Can ‘Terror Management Theory’ Explain Inheritance Spending?

A new study finds inherited wealth is unlike any other windfall, being tied so closely to death.

2 min read

Photo via Erik McGregor/Sipa USA/Newscom

Advisor Upside

Meet the BlackRock ETF Taking Aim at Invesco’s QQQ

The company filed Monday for the iShares Nasdaq 100 ETF, a result of the exchange broadening its US licensing for the index.

2 min read
Photo via Andre M. Chang/ZUMAPRESS/Newscom

Healthcare

Neurocrine Scoops Up Hunger-Drug Maker in Latest Multi-Billion-Dollar Pharma Deal

Soleno Therapeutics’s Vykat XR is the first drug to be approved for treating the insatiable hunger caused by Prader-Willi Syndrome.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.